4//SEC Filing
Elliott Russell P. 4
Accession 0001178913-18-001112
CIK 0001606645other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 12:30 PM ET
Size
5.4 KB
Accession
0001178913-18-001112
Insider Transaction Report
Form 4
Elliott Russell P.
VP Drug Development
Transactions
- Sale
Ordinary Shares
2018-04-02$5.08/sh−142$721→ 12,726 total
Footnotes (1)
- [F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of re-stricted share units. This sale is mandated by the Issuer's non-discretionary policy that requires the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
Documents
Issuer
Foamix Pharmaceuticals Ltd.
CIK 0001606645
Entity typeother
Related Parties
1- filerCIK 0001727807
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 12:30 PM ET
- Size
- 5.4 KB